Search clinical trials for: Gonadotrophin releasing hormone (GnRH) antagonists

Total 70315 results

McGill University Health Centre/Research Institute...

Withdrawn

Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids (eTAPE)

Endometriosis | Fibroids

Canada
Shaare Zedek Medical Center

Recruiting

Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates

Luteal Phase Support

Israel
HaEmek Medical Center, Israel

Completed

Optimal Timing of Intrauterine Insemination (IUI) When Utilizing Superovulation Combined With GnRH Antagonists

Infertility

Israel
IVI Madrid

Completed

Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients (Larganta)

Infertility

Spain
Abbott

Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Puberty, Precocious

United States, Puerto Rico
Joseph Mccune
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases (LUPRON)

Lupus Erythematosus, Systemic | Systemic Vasculitis | Lung Disease With Systemic Sclerosis | Isolated Angiitis of Central Nervous System | Lung Disease Interstitial Diffuse

United States
Cairo University

Completed

Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success

Reproductive Techniques, Assisted
Azienda Ospedaliero-Universitaria di Modena
University of Modena and Reggio Emilia; Ministero della Salute, Italy

Recruiting

Adenomyosis and ART (ADENOFERT)

Adenomyosis

Italy
Eunice Kennedy Shriver National Institute of Child...
National Institutes of Health (NIH); State University of New York - Downstate...

Unknown

Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)

Endometriosis | Dysmenorrhea | Dyspareunia

United States
Chinese University of Hong Kong

Active, not recruiting

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (READT)

Prostate Cancer

Hong Kong
CRG UZ Brussel

Recruiting

Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone (LadyDe)

Oocyte Donation | Oocyte Donors

Belgium
Assaf-Harofeh Medical Center

Recruiting

GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst

Ovarian Cysts | IVF

Israel
University of Southern California

Unknown

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

Ovulation; Failure or Lack of
University of Virginia
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

Polycystic Ovary Syndrome | Hyperandrogenism

United States
Main Line Fertility Center
Ferring Pharmaceuticals

Completed

Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

Fertility

United States
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715) (Care)

Pregnancy | Neonates
University Hospital, Ghent

Recruiting

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders (MONACO)

IVF | Ovarian Reserve | Poor Responders

Belgium
Boston Children's Hospital
Children's Hospital Medical Center, Cincinnati

Recruiting

Skeletal Health and Bone Marrow Composition Among Youth

Puberty | Gender Dysphoria in Children | Bone Development

United States
Royan Institute

Completed

The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

Reproductive Techniques, Assisted | Ovarian Stimulation

Iran, Islamic Republic of
Organon and Co

Completed

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

In Vitro Fertilization
University of Colorado, Denver
National Institute on Aging (NIA)

Not yet recruiting

Cardiometabolic Consequences of the Loss of Ovarian Function (LILAC)

Menopause | Aging | Adiposity | Estrogen Deficiency

United States
ShangHai Ji Ai Genetics & IVF Institute

Recruiting

Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF

Infertility | ART

China
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen KU Leuven

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female

Belgium
Royan Institute

Completed

GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response

Infertility, Female

Iran, Islamic Republic of
Eugonia

Unknown

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome

Greece
Cairo University

Unknown

The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles

Invitro Fertilization

Egypt
Instituto Bernabeu

Not yet recruiting

Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. (PRO_NAT)

IVF
Asan Medical Center

Completed

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer (LEO)

Metastatic Breast Cancer

Korea, Republic of
American University of Beirut Medical Center

Completed

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

Infertility | Sterility

Lebanon
IVI Madrid

Completed

DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

Infertility, Female

Spain
Kuban State Medical University

Active, not recruiting

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Infertility

Russian Federation
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer (DEGASTIM)

Invasive Ductal Breast Carcinoma

France
Cairo University

Unknown

Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

Invitro Fertilizaion

Egypt
Instituto Valenciano de Infertilidad, IVI VALENCIA
Igenomix

Completed

Endometrial Genomic Profile in Endometrial Priming

Genomic Human Endometrial Expression Profile

Spain
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
University of Colorado, Denver
National Center for Advancing Translational Sciences (NCATS)

Completed

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

Obesity | Fertility

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...

Completed

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Prostate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Organon and Co

Completed

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) (Ensure)

Infertility
Università degli Studi dell'Insubria

Not yet recruiting

Surgery and ART For Endometrioma

Infertility, Female | Ovarian Endometrioma
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Stand Up To Cancer

Active, not recruiting

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Metastatic Prostate Cancer

United States
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

Infertility,Female

China
Ferring Pharmaceuticals

Completed

Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

BPH

Germany
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Prostatic Neoplasms

United States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
Centre Hospitalier Universitaire Vaudois
Swiss National Science Foundation

Recruiting

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Kallmann Syndrome | Hypogonadotropic Hypogonadism | Hypothalamic Amenorrhea | Polycystic Ovarian Syndrome | Precocious Puberty | Cleft Lip and Palate | Cleft Palate | Cleft Lip

Switzerland
Takeda

Completed

A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

Central Precocious Puberty

China
Organon and Co

Completed

A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788) (Realize)

In Vitro Fertilization
University of Southern California
National Cancer Institute (NCI); AEterna Zentaris

Completed

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Recurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate Cancer

United States
CMX Research
Ferring Pharmaceuticals

Completed

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (DELAY)

Prostate Cancer

Canada
Ain Shams Maternity Hospital

Unknown

The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS

Infertility

3

Subscribe